PMID- 28966252 OWN - NLM STAT- MEDLINE DCOM- 20180612 LR - 20181202 IS - 1347-5215 (Electronic) IS - 0918-6158 (Linking) VI - 40 IP - 10 DP - 2017 TI - Inhibitory Effects of Polyacetylene Compounds from Panax ginseng on Neurotrophin Receptor-Mediated Hair Growth. PG - 1784-1788 LID - 10.1248/bpb.b17-00205 [doi] AB - Neurotrophins play an important role in the control of the hair growth cycle. Therefore, neurotrophin receptor antagonists have therapeutic potential for the treatment of hair growth disorders. In this study, we investigated the inhibitory effect of Panax ginseng, a medicinal plant commonly used to treat alopecia, on the binding of neurotrophins to their receptors. In addition, we isolated and characterized the bioactive compounds of P. ginseng extracts. P. ginseng hexane extracts strongly inhibited brain-derived neurotrophic factor (BDNF)-TrkB and beta-nerve growth factor (beta-NGF)-p75 neurotrophin receptor (p75NTR) binding. Furthermore, we identified the following 6 polyacetylene compounds as the bioactive components in P. ginseng hexane extract: panaxynol (1), panaxydol (2), panaxydol chlorohydrin (3), 1,8-heptadecadiene-4,6-diyne-3,10-diol (4), panaxytriol (5), and dihydropanaxacol (6). In particular, compounds 4, 5, and 6 significantly inhibited BDNF-TrkB binding in a dose-dependent manner. To identify the structural component mediating the inhibitory effect, we investigated the effects of the hydroxyl moiety in these compounds. We found that the inhibitory effect of panaxytriol (5) was strong, whereas the inhibitory effect of Ac-panaxytriol (7) was relatively weak. Our findings suggest that P. ginseng-derived polyacetylenes with a hydroxyl moiety might provide therapeutic benefits to patients with hair growth disorders such as alopecia by inhibiting the binding of neurotrophins to their receptors. Although saponins have been proposed to be the primary mediators of the effects of P. ginseng on hair growth, this study revealed that polyacetylene compounds exert similar effects. FAU - Suzuki, Aoi AU - Suzuki A AD - Graduate School of Life and Environmental Sciences, University of Tsukuba. FAU - Matsuura, Daisuke AU - Matsuura D AD - Products Development Department, BATHCLIN CORPORATION. FAU - Kanatani, Hirotoshi AU - Kanatani H AD - Products Development Department, BATHCLIN CORPORATION. FAU - Yano, Shingo AU - Yano S AD - Products Development Department, BATHCLIN CORPORATION. FAU - Tsunakawa, Mitsuo AU - Tsunakawa M AD - Products Development Department, BATHCLIN CORPORATION. FAU - Matsuyama, Shigeru AU - Matsuyama S AD - Faculty of Life and Environmental Sciences, University of Tsukuba. FAU - Shigemori, Hideyuki AU - Shigemori H AD - Faculty of Life and Environmental Sciences, University of Tsukuba. LA - eng PT - Journal Article PL - Japan TA - Biol Pharm Bull JT - Biological & pharmaceutical bulletin JID - 9311984 RN - 0 (Brain-Derived Neurotrophic Factor) RN - 0 (Receptor, Nerve Growth Factor) RN - 25067-58-7 (Polyynes) RN - 9061-61-4 (Nerve Growth Factor) RN - EC 2.7.10.1 (Receptor, trkB) SB - IM MH - Brain-Derived Neurotrophic Factor/*metabolism MH - Hair/growth & development MH - Nerve Growth Factor/*metabolism MH - *Panax MH - Polyynes/*pharmacology MH - Receptor, Nerve Growth Factor/*metabolism MH - Receptor, trkB/*metabolism OTO - NOTNLM OT - Panax ginseng OT - brain-derived neurotrophic factor OT - hair growth OT - nerve growth factor OT - polyacetylene EDAT- 2017/10/03 06:00 MHDA- 2018/06/13 06:00 CRDT- 2017/10/03 06:00 PHST- 2017/10/03 06:00 [entrez] PHST- 2017/10/03 06:00 [pubmed] PHST- 2018/06/13 06:00 [medline] AID - 10.1248/bpb.b17-00205 [doi] PST - ppublish SO - Biol Pharm Bull. 2017;40(10):1784-1788. doi: 10.1248/bpb.b17-00205.